Latham & Watkins advised Topgolf Callaway on the transaction, and Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo advised Invited, Inc. Topgolf Callaway Brands Corp. (NYSE: MODG)...
Topgolf Callaway’s $29 Million Acquisition of Bigshots Golf
Viasat’s US$733.4 Million Senior Notes Issue
Latham & Watkins represents Viasat on the offering. Viasat, Inc. (Nasdaq: VSAT), a global communications company, has priced its offering of US$733.4 million in aggregate principal...
Nordson Corporation’s $850 Million Notes Offerings
Latham & Watkins and Taft Stettinius represented Nordson in the offerings, and Simpson Thacher represented the underwriters. Nordson Corporation (Nasdaq: NDSN) closed its offerings of $350...
Thoma Bravo’s Acquisition of NextGen Healthcare
Latham & Watkins advised NextGen Healthcare, Goodwin Procter advised Thoma Bravo, and Skadden advised Morgan Stanley & Co. LLC as financial advisor to NextGen Healthcare on...
PROCEPT BioRobotics’ $172.5 Million Common Stock Offering
Latham & Watkins advised PROCEPT BioRobotics, and Shearman & Sterling advised the underwriters. PROCEPT BioRobotics Corporation announced a follow-on offering of 5,085,494 shares of common stock at...
Skyward Specialty’s Secondary Offering of Common Stock
DLA Piper advised Skyward Specialty, and Latham advised the underwriters. Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) closed on June 12, 2023 its underwritten offering of...
Sterling Check Corp’s Secondary Public Offering
Latham & Watkins advises the underwriters Goldman Sachs & Co. and J.P. Morgan Securities, on Sterling Check Corp.’s secondary public offering. Sterling Check Corp., a leading...
Merck’s Acquisition of Prometheus Biosciences
Paul, Weiss, Rifkind, Wharton & Garrison represented Merck, Latham & Watkins represented Prometheus, Skadden represented the financial advisors on the deal. Prometheus Biosciences, Inc. have entered...
QuantaSing’s $40 Million IPO
Wilson Sonsini represented QuantaSing, while Latham & Watkins advised the joint bookrunners on the offering. QuantaSing Group Limited announced the pricing of its initial public offering...
Bausch + Lomb’s Acquisition of AcuFocus
Latham & Watkins LLP represented AcuFocus in the transaction. Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see...
Skyward Specialty’s $134 Million Upsized Initial Public Offering
DLA Piper advised Skyward Specialty, while Latham & Watkins LLP represented the underwriters in the offering. Skyward Specialty Insurance Group, Inc., a specialty insurance company, delivering...
Alphatec Spine’s $200 Million Growth Financing Facilities
Latham & Watkins LLP represented Alphatec in the transactions. Alphatec Holdings, Inc. (Nasdaq: ATEC), a medical technology company focusing on surgical treatment for spinal disorders has...